selected scholarly activity
-
journal articles
- In rifampicin-resistant TB, bedaquiline-containing regimens reduced unfavorable status vs. a control regimen at 132 wk.. ACP journal club. 178:JC19. 2025
- Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.. Advances in Therapy. 42:666-719. 2025
- Why randomized controlled trials are necessary to address the effectiveness of non-pharmacological interventions during a public health emergency such as COVID-19. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 9:197-199. 2024
- How is ceftobiprole used in Canada: the CLEAR study final results. Expert Review of Anti-Infective Therapy. 22:1-8. 2024
- Evaluating in vivo effectiveness of sotrovimab for the treatment of Omicron subvariant BA.2 versus BA.1: a multicentre, retrospective cohort study. BMC Research Notes. 17:37. 2024
- In outpatients with COVID-19 during Omicron variant circulation, molnupiravir and nirmatrelvir–ritonavir improved outcomes. ACP journal club. 177:JC7-JC7. 2024
- Knowledge, attitudes, and practices towards Human Papilloma Virus and uptake of HPV vaccine: A protocol for a systematic review.. PLoS ONE. 19:e0313887. 2024
- Overprescription of antibiotics for treating hospitalized COVID-19 patients: A systematic review & meta-analysis. Trials in Vaccinology. 9:e20563-e20563. 2023
- Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations. International Journal of Infectious Diseases. 134:228-238. 2023
- Eosinophil-independent IL-5 levels are increased in critically ill COVID-19 patients who survive. Allergy, Asthma and Clinical Immunology. 19:58. 2023
- Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers. ACP journal club. 176:eL230077. 2023
- Early Experience with Modified Dose Nirmatrelvir/Ritonavir in Dialysis Patients with Coronavirus Disease 2019. American Society of Nephrology. Clinical Journal. 18:485-490. 2023
- In critically ill patients with COVID-19, IL-6 receptor antagonists reduced mortality vs. control at 180 d. ACP journal club. 176:JC41-JC41. 2023
- Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: A prospective cohort study. PLoS ONE. 18:e0281673-e0281673. 2023
- Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers. ACP journal club. 175:1629-1638. 2022
- Multistudy Research Operations in the ICU: An Interprofessional Pandemic-Informed Approach. Critical Care Explorations. 4:e0808-e0808. 2022
- Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD. American Society of Nephrology. Clinical Journal. 17:1247-1250. 2022
- In high-risk outpatients with COVID-19, remdesivir reduced COVID-19–related hospitalization or all-cause death at 28 d. ACP journal club. 175:JC50-JC50. 2022
- Comparing the usability of the World Health Organization’s conventional tuberculosis guidelines to the eTB recommendations map: A two-arm superiority randomised controlled trial. PLOS Global Public Health. 2:e0001166-e0001166. 2022
- Re: It Is Time to Address Airborne Transmission of COVID-19. Clinical Infectious Diseases. 73:e3981-e3982. 2021
- A regional Canadian expert consensus on recommendations for restoring exercise and pulmonary function testing in low and moderate-to-high community prevalence coronavirus disease 2019 (COVID-19) settings. Infection Control and Hospital Epidemiology. 42:1535-1537. 2021
- In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d. ACP journal club. 174:JC125-JC125. 2021
- Assessment of the Burden of SARS-CoV-2 Variants of Concern Among Essential Workers in the Greater Toronto Area, Canada. JAMA network open. 4:e2130284-e2130284. 2021
- COVID-19 boosters in rich nations will delay vaccines for all. Nature Medicine. 27:1659-1660. 2021
- The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. Journal of Allergy and Clinical Immunology: In Practice. 9:3546-3567. 2021
- In patients with COVID-19, viral shedding time is 17 d and varies in some subgroups. ACP journal club. 174:JC94-JC94. 2021
- In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant). ACP journal club. 174:JC50-JC50. 2021
- Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects. Viruses. 13:697-697. 2021
- In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose. ACP journal club. 174:JC29-JC29. 2021
- In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose. ACP journal club. 174:JC28-JC28. 2021
- The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose. ACP journal club. 174:JC15-JC15. 2021
- Tocilizumab versus the Covid19 tempest: All’s well that ends well or much ado about nothing?. Clinical Microbiology and Infection (CMI). 27:158-159. 2021
- The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials. PLoS ONE. 16:e0244778-e0244778. 2021
- Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19. Open Forum Infectious Diseases. 7:ofaa500. 2020
- Desperate times call for evidence-based measures: Prioritizing science during the COVID-19 pandemic. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 5:127-129. 2020
- Utility of asymptomatic inpatient testing for COVID-19 in a low-prevalence setting: A multicenter point-prevalence study. Infection Control and Hospital Epidemiology. 41:1233-1235. 2020
- Novel Coronavirus COVID-19. Journal of Bone and Joint Surgery. American volume. 102:734-744. 2020
- Haemophilus influenzae type b necrotizing fasciitis in an adult with common variable immunodeficiency. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 5:44-48. 2020
- Cryptococcemia presenting as an opportunistic infection due to chronic visceral leishmaniasis. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 4:178-181. 2019
- Successful use of intrathecal colistin in the treatment of Pseudomonas aeruginosa ventriculitis. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 2:93-96. 2017
- Distribution of hepatitis B virus infection in Namibia. SAMJ - South African Medical Journal. 107:882-882. 2017
- Case Report of Necrotizing Fasciitis Associated withStreptococcus pneumoniae. Canadian Journal of Infectious Diseases and Medical Microbiology. 2016:1-4. 2016
- Disseminated Cryptococcal Disease in Non-HIV, Nontransplant Patient. Case Reports in Infectious Diseases. 2016:1-4. 2016
- A Venomous Visitor from the Tropics. Canadian Journal of Infectious Diseases and Medical Microbiology. 26:243-244. 2015
- Melioidosis in a Returned Traveller. Canadian Journal of Infectious Diseases and Medical Microbiology. 25:225-226. 2014
- Chronic norovirus infection in a transplant patient successfully treated with enterally administered immune globulin. Journal of Clinical Virology. 58:306-308. 2013
- Genetically Typed Community‐Acquired Methicillin‐Resistant Staphylococcus aureus in a Canadian Hospital. Canadian Journal of Infectious Diseases and Medical Microbiology. 20:e113-e114. 2009